New FDA Roadmap App helps sponsors improve clinical research

The new FDA Roadmap App from PHT Corporation helps sponsors navigate the Roadmap to Patient-Focused Outcome Measurement in Clinical Trials released by the FDA with their Clinical Outcome Assessment Qualification Program. The program and roadmap highlight the process by which sponsors should consider, choose and/or develop clinical program patient-focused outcome measurement strategies. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.

The FDA Roadmap app optimizes the roadmap for Android phones and tablets. See it and download the Android app: http://www.phtcorp.com/Resources/Apps/FDA-Roadmap-App.aspx or download it via Google Play: http://bit.ly/PHTs-FDA-Roadmap-Android

The Roadmap helps trial sponsors improve clinical research that collects patient data through understanding the disease or condition, conceptualizing the treatment benefit resulting in identification of the targeted context of use (COU), and concept of interest (COI) for future clinical trial measurement.

PHT Vice President of Marketing and Product Management Sheila Rocchio said, "Clinical trials are including more patient reported outcomes (PROs) since the publication of the FDA Patient Reported Outcome (PRO) Guidance, The new app helps clinical research professionals quickly and easily reference roadmap content."

The FDA Roadmap App exemplifies PHT innovation in mobile technology for clinical research. The PHT LogPad^® System which collects compliant patient data using smartphones has been a finalist for the Clinical Informatics News Best Practices and SCDM Data Driven Innovation awards.